Christos Nicholoudis - Net Worth and Insider Trading

Christos Nicholoudis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christos Nicholoudis owns 1 companies in total, including Mira Pharmaceuticals Inc (MIRA) .

Click here to see the complete history of Christos Nicholoudis’s form 4 insider trades.

Insider Ownership Summary of Christos Nicholoudis

Ticker	Comapny	Transaction Date	Type of Owner
MIRA	Mira Pharmaceuticals Inc	2023-08-02	director

Christos Nicholoudis Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christos Nicholoudis Ownership Network

Ownership Network List of Christos Nicholoudis

No Data

Ownership Network Relation of Christos Nicholoudis

Christos Nicholoudis Owned Company Details

What does Mira Pharmaceuticals Inc do?

Who are the key executives at Mira Pharmaceuticals Inc?

Christos Nicholoudis is the director of Mira Pharmaceuticals Inc. Other key executives at Mira Pharmaceuticals Inc include 10 percent owner Brian Patrick Mcnulty , 10 percent owner George Cappy , and director & Executive Chairman Chapman Christopher C Jr .

Mira Pharmaceuticals Inc (MIRA) Insider Trades Summary

Over the past 18 months, Christos Nicholoudis made no insider transaction in Mira Pharmaceuticals Inc (MIRA). Other recent insider transactions involving Mira Pharmaceuticals Inc (MIRA) include a net purchase of 276,218 shares made by George Cappy , and a net sale of 238,095 shares made by Brian Patrick Mcnulty .

In summary, during the past 3 months, insiders sold 0 shares of Mira Pharmaceuticals Inc (MIRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,095 shares of Mira Pharmaceuticals Inc (MIRA) were sold and 276,218 shares were bought by its insiders, resulting in a net purchase of 38,123 shares.

Mira Pharmaceuticals Inc (MIRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mira Pharmaceuticals Inc Insider Transactions

No Available Data

Christos Nicholoudis Mailing Address

Above is the net worth, insider trading, and ownership report for Christos Nicholoudis. You might contact Christos Nicholoudis via mailing address: C/o Mira Pharmaceuticals, Inc., 900 West Platt Street, Suite 200, Tampa Fl 33606-2173.

Discussions on Christos Nicholoudis

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.